Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation.
Sheil, A G
Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. [electronic resource] - Transplantation proceedings - 825-7 p. digital
Publication Type: Journal Article
0041-1345
10.1016/s0041-1345(96)00151-0 doi
Actuarial Analysis
Australia
Confidence Intervals
Follow-Up Studies
Heart Transplantation--mortality
Humans
Incidence
Kidney Transplantation--mortality
Liver Transplantation--mortality
Lymphoma, Non-Hodgkin--epidemiology
Neoplasms--epidemiology
Postoperative Complications
Registries
Retrospective Studies
Survival Rate
Time Factors
Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. [electronic resource] - Transplantation proceedings - 825-7 p. digital
Publication Type: Journal Article
0041-1345
10.1016/s0041-1345(96)00151-0 doi
Actuarial Analysis
Australia
Confidence Intervals
Follow-Up Studies
Heart Transplantation--mortality
Humans
Incidence
Kidney Transplantation--mortality
Liver Transplantation--mortality
Lymphoma, Non-Hodgkin--epidemiology
Neoplasms--epidemiology
Postoperative Complications
Registries
Retrospective Studies
Survival Rate
Time Factors